Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa D Barnes

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Clinical Microbiology|June 7, 2019
"Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant <i>Burkholderia cepacia</i> Complex and <i>Burkholderia gladioli</i> Cystic Fibrosis IsolatesElise T Zeiser, Scott A Becka, Brigid M Wilson, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2019
Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant <i>Burkholderia</i> Species Isolates from the United StatesElise T Zeiser, Scott A Becka, Melissa D Barnes, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by AvibactamMelina Ruggiero, Krisztina M Papp-Wallace, Florencia Brunetti, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by RelebactamMelissa D Barnes, Christopher R Bethel, Jim Alsop, et al.
Scientific Reports|August 29, 2018
Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistanceIoannis Galdadas, Silvia Lovera, Guillermo Pérez-Hernández, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
The Effectiveness of Imipenem-Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-LactamaseKrisztina M Papp-Wallace, Melissa D Barnes, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by AvibactamMichiyoshi Nukaga, Krisztina M Papp-Wallace, Tyuji Hoshino, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Characterization of the AmpC β-Lactamase from Burkholderia multivoransScott A Becka, Elise T Zeiser, Melissa D Barnes, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to AztreonamMaria F Mojica, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Clinical Microbiology|June 7, 2019
"Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant <i>Burkholderia cepacia</i> Complex and <i>Burkholderia gladioli</i> Cystic Fibrosis IsolatesElise T Zeiser, Scott A Becka, Brigid M Wilson, et al.
Antimicrobial Agents and Chemotherapy|February 6, 2019
Resurrecting Old β-Lactams: Potent Inhibitory Activity of Temocillin against Multidrug-Resistant <i>Burkholderia</i> Species Isolates from the United StatesElise T Zeiser, Scott A Becka, Melissa D Barnes, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
Structural Insights into the Inhibition of the Extended-Spectrum β-Lactamase PER-2 by AvibactamMelina Ruggiero, Krisztina M Papp-Wallace, Florencia Brunetti, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2018
Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by RelebactamMelissa D Barnes, Christopher R Bethel, Jim Alsop, et al.
Scientific Reports|August 29, 2018
Defining the architecture of KPC-2 Carbapenemase: identifying allosteric networks to fight antibiotics resistanceIoannis Galdadas, Silvia Lovera, Guillermo Pérez-Hernández, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
The Effectiveness of Imipenem-Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-LactamaseKrisztina M Papp-Wallace, Melissa D Barnes, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by AvibactamMichiyoshi Nukaga, Krisztina M Papp-Wallace, Tyuji Hoshino, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2018
Characterization of the AmpC β-Lactamase from Burkholderia multivoransScott A Becka, Elise T Zeiser, Melissa D Barnes, et al.
Antimicrobial Agents and Chemotherapy|April 4, 2018
Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing EnterobacteriaceaeKrisztina M Papp-Wallace, Melissa D Barnes, Jim Alsop, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2017
Avibactam Restores the Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia to AztreonamMaria F Mojica, Krisztina M Papp-Wallace, Magdalena A Taracila, et al.
Pageof 2